A Novel Platform for Antibody Discovery, Engineering and Validation
The Technology
![](https://abbratech.com/wp-content/uploads/2021/04/Mab123.png)
About Us
How we became who we are
![](https://abbratech.com/wp-content/uploads/2021/05/abbratech-17-1024x768.jpg)
What We Do
"Our team is composed of a group of scientists with years of antibody engineering experience. We have developed methods for phage display, immunorepertoire analysis and B cell cloning. Our experience, combined with a desire to tackle some of the more difficult antigen targets is what will make us successful."
- CEO & Founder, Michael P Weiner, Ph.D.
Our Team
Leadership
![](https://abbratech.com/wp-content/uploads/image-2.png)
Founder & CEO
Michael P Weiner, Ph.D.
Dr. Weiner is a serial scientific entrepreneur and the Founder of Abbratech Inc.
![](https://abbratech.com/wp-content/uploads/1552323089047.jpg)
Chief Business Officer
Troy Lionberger, Ph.D.
Dr. Lionberger is a biologist and business developer focused on leveraging innovative technologies to advance drug discovery
![](https://abbratech.com/wp-content/uploads/linda.jpg)
Executive Director
Linda Stevens
Linda has over 20 years of Biotech experience from earliest of stages of startup to mergers and acquisitions
Board of Directors
![](https://abbratech.com/wp-content/uploads/image-2.png)
Founder & CEO
Michael P Weiner, Ph.D.
Dr. Weiner is a serial scientific entrepreneur and the Founder of Abbratech Inc.
![](https://abbratech.com/wp-content/uploads/Michael-Egholm.png)
Board of Directors Member
Michael Egholm, Ph.D.
Dr. Egholm brings more than 27 years of proven leadership in developing and commercializing innovative technologies.
![](https://abbratech.com/wp-content/uploads/Sean-Mackay.png)
Board of Directors Member
Sean Mackay
Sean Mackay co-founded and leads IsoPlexis as CEO. IsoPlexis’ mission is to provide widely accessible cellular proteomics to speed personalized, curative medicines.
![](https://abbratech.com/wp-content/uploads/Sean-Cassidy-scaled.jpg)
Board of Directors Member
Sean Cassidy
Mr. Cassidy is the Chief Financial Officer of Arvinas with over 20 years of experience in the life sciences industry
![](https://abbratech.com/wp-content/uploads/Kenan.jpg)
Board of Directors Member
Kenan Turnacioglu, Ph.D.
Dr. Turnacioglu is currently Chairperson of PaigeAI, a machine learning Pathology company spun out of Memorial Sloan Kettering
Medical Advisory Board
![](https://abbratech.com/wp-content/uploads/image.png)
Medical Advisory Board
John Hastewell, DPhil
John Hastewell served in many roles in his nearly 30 years at Novartis.
![](https://abbratech.com/wp-content/uploads/Robert-Hollingsworth.jpeg)
Medical Advisory Board
Robert Hollingsworth, Ph.D.
Dr. Hollingsworth is the Chief Scientific Officer at Shoreline Biosciences.
![](https://abbratech.com/wp-content/uploads/Rachel-W.-Humphrey-Headshot.jpg)
Medical Advisory Board
Rachel Humphrey, M.D
Dr. Humphrey is the President and CEO of an Immuno-oncology start-up.
![](https://abbratech.com/wp-content/uploads/unnamed.jpg)
Medical Advisory Board
Ulf Landegren, M.D., Ph.D
Ulf Landegren received his MD and PhD in Uppsala, Sweden, before spending five years at California Institute of Technology
Technical Advisory Board
![](https://abbratech.com/wp-content/uploads/Michael-Synder.png)
Technical Advisory Board
Michael P. Snyder, Ph.D.
Michael Snyder is the Stanford Ascherman Professor, Chair of Genetics, and Director of the Center of Genomics and Personalized Medicine.
![](https://abbratech.com/wp-content/uploads/dieter.jpg)
Technical Advisory Board
Dieter Söll, Ph.D.
Dieter Gerhard Söll is a Sterling Professor of Molecular Biophysics and Biochemistry and Chemistry at the Yale University.
![](https://abbratech.com/wp-content/uploads/weitz.png)
Technical Advisory Board
David Weitz, Ph.D.
David A. Weitz is the Mallinckrodt Professor of Physics and Applied Physics at Harvard University.